Skip to main content
GemVax & KAEL Co.,Ltd. logo

GemVax & KAEL Co.,Ltd. — Investor Relations & Filings

Ticker · 082270 ISIN · KR7082270000 KO Manufacturing
Open in API
Filings indexed 656 across all filing types
Latest filing 2026-06-19 Capital/Financing Update
Country KR South Korea
Listing KO 082270

About GemVax & KAEL Co.,Ltd.

https://gemvax.com/

GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.

Recent filings

Filing Released Lang Actions
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Capital/Financing Update Classification · 95% confidence The document is primarily a detailed disclosure about a stock collateral contract accompanying a change in the largest shareholder. It includes information about the debt amounts, collateral stock totals, contract dates, parties involved, and conditions of collateral execution. The nature of the document focuses on financial obligations secured against shares, changes in ownership stakes, and related contracts. It does not include financial results or operational data nor does it reference a meeting or governance changes specifically. The document is not an announcement of a report but a regulatory disclosure of share collateral tied to controlling shareholder changes. Therefore, this fits best as a Capital/Financing Update due to the updates on stock collateral involving the largest shareholder and debt terms.
2026-06-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' which translates to 'Report of Ownership Status of Specific Securities by Executives and Major Shareholders'. It includes details about share ownership, ownership percentages, changes in ownership, and transaction information of a company executive (namely 남 경 필). There are references to securities market regulations and reporting to regulatory bodies like the Securities and Futures Commission and Korea Exchange. This type of document is used for reporting insider share ownership and changes thereto per regulatory requirements, which fits the definition of 'Director's Dealing' as it reports personal share transactions or ownership changes by company directors and executives. The document is not an annual or interim report, nor an announcement of voting results or capital changes. It contains no financial statements but detailed ownership data.
2026-06-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document text is predominantly about disclosures of large shareholding positions involving a company and its affiliates, including details on share quantities, ownership percentages, related contracts, and voting rights delegations. It references terms such as "주식등의 대량보유상황보고서" which translates to "Report on Large Shareholding Status" and includes tables listing major shareholders, their shareholdings, special relationships, shareholding changes, and related contractual arrangements. There is no indication of quarterly or annual financial statements, audit reports, management changes, dividend declarations, or earnings summaries. The content fits the criteria of a major shareholding notification, where significant share ownership or changes to it are reported as required by securities regulations. Therefore, the appropriate classification is "Major Shareholding Notification" with code MRQ.
2026-06-17 Korean
[기재정정]최대주주변경을수반하는주식담보제공계약체결
Capital/Financing Update Classification · 95% confidence The document is a detailed disclosure of a stock pledge agreement involving a change in the major shareholder ('최대주주 변경을 수반하는 주식 담보제공 계약 체결'). It includes specifics about debt amounts, pledged shares, contract dates, conditions for execution of pledge rights, and related parties. The disclosure is regulatory in nature concerning share pledges linked to financing and shareholder structure changes. There is no indication that this is an earnings release, annual report, or proxy solicitation. It is an announcement related to financing activities and capital structure via share pledge agreements. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail exclude it being just a report publication announcement or a minor regulatory filing.
2026-06-15 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 78% confidence The document is a regulatory announcement of an upcoming investor relations meeting (IR) with details on date, time, venue, attendees, and purpose. It does not contain actual financial statements or presentation content/slides. It is not a full report (10-K, IR, ER, etc.) nor an AGM or proxy solicitation. It fits the catch-all category for general regulatory notices (RNS).
2026-06-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a Korean "주식등의 대량보유상황보고서" filed under the Capital Markets Act, detailing a large shareholder’s holdings, changes in share count, ownership percentages, and related contracts. This matches a Major Shareholding Notification. It is not an announcement of a report nor an interim or annual report, but the filing itself of a significant shareholding report.
2026-06-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.